AI Tokens
Stock Analysis on Net

Abbott Laboratories (NYSE:ABT)

Income Statement
Quarterly Data

The income statement presents information on the financial results of a company business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.

Abbott Laboratories, consolidated income statement (quarterly data)

US$ in millions

Microsoft Excel
3 months ended: Sep 30, 2026 Jun 30, 2026 Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net sales 13,013 12,593 11,164 11,459 11,369 11,142 10,358 10,974 10,635 10,377 9,964 10,241 10,143 9,978 9,747 10,091 10,410 11,257 11,895 11,468 10,928 10,223 10,456
Cost of products sold, excluding amortization of intangible assets (5,628) (5,325) (4,890) (4,922) (5,075) (4,854) (4,468) (4,942) (4,698) (4,603) (4,463) (4,556) (4,605) (4,483) (4,331) (4,593) (4,629) (4,933) (4,987) (4,766) (4,423) (4,947) (4,401)
Amortization of intangible assets (841) (658) (422) (422) (420) (420) (420) (465) (470) (471) (472) (481) (496) (498) (491) (496) (498) (507) (512) (514) (520) (504) (509)
Gross profit 6,544 6,610 5,852 6,115 5,874 5,868 5,470 5,567 5,467 5,303 5,029 5,204 5,042 4,997 4,925 5,002 5,283 5,817 6,396 6,188 5,985 4,772 5,546
Research and development (920) (892) (767) (735) (766) (725) (716) (749) (713) (698) (684) (700) (672) (715) (654) (725) (782) (684) (697) (762) (672) (654) (654)
Selling, general and administrative (4,266) (4,025) (3,740) (3,129) (3,051) (3,091) (3,061) (2,907) (2,895) (2,936) (2,959) (2,724) (2,723) (2,740) (2,762) (2,973) (2,731) (2,757) (2,787) (3,048) (2,767) (2,726) (2,783)
Operating earnings 1,358 1,693 1,345 2,251 2,057 2,052 1,693 1,911 1,859 1,669 1,386 1,780 1,647 1,542 1,509 1,304 1,770 2,376 2,912 2,378 2,546 1,392 2,109
Interest expense (350) (351) (174) (120) (121) (121) (131) (136) (142) (140) (141) (159) (166) (159) (153) (154) (141) (132) (131) (131) (133) (134) (135)
Interest income 53 52 106 78 77 71 82 91 91 82 80 89 97 98 101 88 55 26 14 11 10 11 11
Net foreign exchange gain (loss) 6 (4) 13 15 17 11 7 10 11 6 — (24) 10 (21) (6) 14 (19) — 3 6 (4) — (3)
Other income (expense), net 164 134 159 134 150 137 127 154 121 (10) 111 109 83 176 111 68 93 82 78 63 74 79 61
Earnings before taxes 1,231 1,524 1,449 2,358 2,180 2,150 1,778 2,030 1,940 1,607 1,436 1,795 1,671 1,636 1,562 1,320 1,758 2,352 2,876 2,327 2,493 1,348 2,043
Taxes on earnings (311) (596) (372) (582) (536) (371) (453) 7,199 (294) (305) (211) (201) (235) (261) (244) (287) (323) (334) (429) (338) (393) (159) (250)
Net earnings 920 928 1,077 1,776 1,644 1,779 1,325 9,229 1,646 1,302 1,225 1,594 1,436 1,375 1,318 1,033 1,435 2,018 2,447 1,989 2,100 1,189 1,793

Based on: 10-Q (reporting date: 2026-09-30), 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).


Net sales exhibit a cyclical pattern, reaching a trough of 9,747 million dollars in March 2023 before entering a period of sustained growth. Revenue peaked at 13,013 million dollars by June 2026, representing a significant recovery and expansion from the 2022-2023 lows. Gross profit generally tracked this revenue trajectory, recovering from 4,925 million dollars in March 2023 to a high of 6,610 million dollars in March 2026.

Operational Expense Trends
Research and development expenditures remained relatively stable between 650 million and 760 million dollars for much of the period, followed by a strategic increase to over 900 million dollars in mid-2026. Selling, general, and administrative expenses showed a marked escalation starting in March 2026, rising from approximately 3 billion dollars to 4,266 million dollars by September 2026. This rapid increase in SG&A outpaced revenue growth in the final quarters, placing downward pressure on operating margins.
Operating Earnings and Profitability
Operating earnings fluctuated considerably, with a notable decline observed in 2022 and 2023. While earnings recovered to 2,251 million dollars by December 2025, they dropped sharply to 1,358 million dollars by September 2026. This contraction is primarily attributable to the aforementioned surge in operating expenses and an increase in the cost of products sold during the same period.
Non-Operating Items and Tax Anomalies
Interest expenses remained stable around 130 million to 160 million dollars until early 2026, when they spiked to 350 million dollars per quarter. A significant financial anomaly is observed in December 2024, where taxes on earnings recorded a positive value of 7,199 million dollars, resulting in an exceptional net earnings spike of 9,229 million dollars for that quarter. Excluding this outlier, net earnings show a general downward trend in 2026, falling to 920 million dollars by September 2026.

The overall financial trajectory indicates a successful expansion of the top line, countered by a significant increase in the cost of operations and financing in 2026. The divergence between increasing net sales and declining operating earnings in the final quarters suggests a decrease in operational efficiency or a period of heavy investment in administrative and promotional infrastructure.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?